Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus
J. Clin. Invest. Kristina I. Rother, et al. 114:877 doi:10.1172/JCI23235 [Go to this article.]

Table 1
Systemic side effects commonly associated with the immunosuppressive agents typically administered following islet transplant